Analysts Set Merck KGaA (MRK) Price Target at $108.90
Shares of Merck KGaA (FRA:MRK) have received a consensus rating of “Hold” from the twenty-two research firms that are presently covering the firm, Marketbeat.com reports. Sixteen equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is €108.90 ($128.12).
MRK has been the subject of a number of research reports. Nord/LB reiterated a “neutral” rating on shares of Merck KGaA in a report on Wednesday, June 28th. Credit Suisse Group set a €106.00 ($124.71) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Wednesday, July 26th. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Thursday, August 17th. DZ Bank AG reiterated a “neutral” rating on shares of Merck KGaA in a report on Monday, May 29th. Finally, Kepler Capital Markets set a €119.00 ($140.00) price objective on shares of Merck KGaA and gave the company a “buy” rating in a report on Monday, July 31st.
Merck KGaA (FRA MRK) traded up 0.867% on Tuesday, hitting €92.973. 425 shares of the stock traded hands. The stock has a market cap of €40.42 billion and a P/E ratio of 24.237. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The stock has a 50-day moving average price of €95.91 and a 200 day moving average price of €103.18.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.